Nimesulide Market

Nimesulide is a relatively COX-2 selective, non-steroidal anti-inflammatory drug (NSAID) with analgesic and antipyretic properties. Its approved indications are the treatment of acute pain, the symptomatic treatment of osteoarthritis and primary dysmenorrhoea in adolescents and adults above 12 years old. Due to concerns about the risk of hepatotoxicity, nimesulide has been withdrawn from market in many countries.

Nimesulide Market contains market size and forecasts of Nimesulide in global, including the following market information:

Global Nimesulide Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Nimesulide Market Sales, 2017-2022, 2023-2028, (KG)

Global top five Nimesulide companies in 2021 (%)

The global Nimesulide market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Tablets Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Nimesulide include Helsinn, Therabel, Boehringer Ingelheim, Merck, Roche, Novartis, Medea Research, Chinoin and GSK, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Nimesulide manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Nimesulide Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (KG)

Global Nimesulide Market Segment Percentages, by Type, 2021 (%)

Tablets

Capsule

Granules

Other

Global Nimesulide Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (KG)

Global Nimesulide Market Segment Percentages, by Application, 2021 (%)

Chronic Arthritis

Primary Dysmenorrhea

Traumatic Pain

Post-Operative Pain

Other

Global Nimesulide Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (KG)

Global Nimesulide Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Nimesulide revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Nimesulide revenues share in global market, 2021 (%)

Key companies Nimesulide sales in global market, 2017-2022 (Estimated), (KG)

Key companies Nimesulide sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Helsinn

Therabel

Boehringer Ingelheim

Merck

Roche

Novartis

Medea Research

Chinoin

GSK

Alter

Bayer

Rafa Laboratories

Grunenthal

Pfizer

Sanofi

Italfarmaco

Lepu Pharmaceutical

Nanchang Feihong Pharmaceutical

Sinopharm

Guangdong Longxin Pharmaceutical

Kangzhi Pharmaceutical

Hubei Shubang Pharmaceutical

Mudanjiang Lingtai Pharmaceutical

Guizhou Jisheng Pharmaceutical

Tianjin Hezhi Pharmaceutical Group

Guangdong Yishu Pharmaceutical

Guangzhou Baiyunshan Pharmaceutical

Hainan Huluwa Pharmaceutical

Nanjing Zhengke Pharmaceutical